Single Cell Discoveries

Executive Summary

Single Cell Discoveries is a Netherlands-based contract research organization (CRO) specializing in transcriptomics, offering end-to-end, technology-agnostic services for bulk, single-cell, and spatial RNA sequencing. Founded in 2012, the company provides fully analyzed data within four weeks, targeting researchers who need high-quality, reliable data for critical decisions. As a scientist-led organization, it differentiates itself through rigorous quality control and rapid turnaround times. The CRO model provides recurring revenue and scalability, with the global single-cell and spatial genomics market expected to grow significantly, driven by oncology, neuroscience, and immunotherapy research. However, the company operates in a competitive landscape with larger players like 10x Genomics and other specialized CROs. Its private status limits visibility into financials, but its long-standing presence and focus on quality suggest a stable niche position. The conviction score is moderate, reflecting the steady demand for transcriptomics services but tempered by competition and lack of disclosed growth metrics.

Upcoming Catalysts (preview)

• Q4 2026Launch of expanded spatial transcriptomics service line70% success
• Q2 2027Strategic partnership with a top-20 pharmaceutical company40% success
• Q1 2027Series A or B funding round to fuel international expansion50% success